SCHEMBL2053397

SCHEMBL2053397

Cc1ccc2c(C)ccc(C(=O)N(C)[C@H](CCNC(=O)c3cccn3C)Cc3ccccc3)c2n1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCRTR1 O43613 2/20 0.55
HCRTR2 O43614 2/20 0.55
NPC1 O15118 2/20 0.44
RAB9A P51151 2/20 0.44
PADI4 Q9UM07 3/20 0.35
ALDH1A1 P00352 3/20 0.35
KDM4E B2RXH2 2/20 0.35
GAA P10253 1/20 0.35
HPGD P15428 1/20 0.35
ADORA2A P29274 1/20 0.34
ADORA1 P30542 1/20 0.34
MEN1 O00255 1/20 0.34
UBE2N P61088 1/20 0.34
KMT2A Q03164 1/20 0.34
TSHR P16473 1/20 0.33
CASP1 P29466 1/20 0.33
CASP7 P55210 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
HSD17B10 Q99714 1/20 0.33
HRH3 Q9Y5N1 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2016967 1.00 HCRTR1 (0.55) HCRTR1HCRTR2NPC1RAB9APADI4
SCHEMBL2011240 0.90 HCRTR1 (0.58) HCRTR1HCRTR2NPC1RAB9APADI4
SCHEMBL2054318 0.90 HCRTR1 (0.58) HCRTR1HCRTR2NPC1RAB9APADI4
SCHEMBL2012853 0.89 HCRTR1 (0.59) HCRTR1HCRTR2NPC1RAB9APADI4
SCHEMBL2017008 0.84 HCRTR1 (0.56) HCRTR1HCRTR2NPC1RAB9APADI4
SCHEMBL2054419 0.83 HCRTR1 (0.58) HCRTR1HCRTR2NPC1RAB9APADI4
SCHEMBL2013457 0.83 HCRTR1 (0.58) HCRTR1HCRTR2NPC1RAB9APADI4
SCHEMBL2017894 0.83 HCRTR1 (0.59) HCRTR1HCRTR2NPC1RAB9AALDH1A1
SCHEMBL2052571 0.83 HCRTR1 (0.59) HCRTR1HCRTR2NPC1RAB9AALDH1A1
SCHEMBL2010539 0.82 HCRTR1 (0.63) HCRTR1HCRTR2NPC1RAB9APADI4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011073316-A1 4-ARYL-BUTANE-1,3-DIAMIDES NOVARTIS AG (CH) 2011-06-23 WO disclosed